Dow Jones

40,211.72

0.53%

Regístrate gratis para obtener cotizaciones en tiempo real, gráficos interactivos, flujo de opciones en vivo y más.

Regístrate

Inicio
Invertir
Acciones
Estados Unidos
NASDAQ
Syneron Medical Ltd. - Ordinary Shares (ELOS)
Syneron Medical Ltd. - Ordinary Shares (ELOS) Noticias

ELOS

Syneron Medical Ltd. - Ordinary Shares (ELOS)

Syneron Medical Ltd. - Ordinary Shares

Fecha:

Regulatory News

Text Search:

Ordernar por:

Non-Regulatory News

Showing the most relevant articles for your search:NASDAQ:ELOS

1 2 3 4 5 6 7 8 9 10 Próxima >

Fecha	Hora	Fuente	Título	Símbolo	Compañía
10/05/2017	05:13	Edgar (US Regulatory)	Statement of Beneficial Ownership (sc 13d)	NASDAQ:ELOS	Syneron Medical Ltd. - Ordinary Shares
10/05/2017	05:00	PR Newswire (US)	Syneron Candela Announces End of Go-Shop Period	NASDAQ:ELOS	Syneron Medical Ltd. - Ordinary Shares
01/05/2017	15:37	Edgar (US Regulatory)	Report of Foreign Issuer (6-k)	NASDAQ:ELOS	Syneron Medical Ltd. - Ordinary Shares
19/04/2017	09:50	Edgar (US Regulatory)	Amended Statement of Ownership (sc 13g/a)	NASDAQ:ELOS	Syneron Medical Ltd. - Ordinary Shares
03/04/2017	11:31	Edgar (US Regulatory)	Confidential Treatment Order (ct Order)	NASDAQ:ELOS	Syneron Medical Ltd. - Ordinary Shares
27/03/2017	03:00	PR Newswire (US)	Syneron Candela Announces CE Mark for CO2RE® Intima	NASDAQ:ELOS	Syneron Medical Ltd. - Ordinary Shares
23/03/2017	15:10	PR Newswire (US)	Syneron Medical Ltd. Announces Availability of its Annual Report on Form 20-F through its Website	NASDAQ:ELOS	Syneron Medical Ltd. - Ordinary Shares
23/03/2017	14:43	Edgar (US Regulatory)	Annual and Transition Report (foreign Private Issuer) (20-f)	NASDAQ:ELOS	Syneron Medical Ltd. - Ordinary Shares
20/03/2017	15:07	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:ELOS	Syneron Medical Ltd. - Ordinary Shares
01/03/2017	14:05	PR Newswire (US)	Syneron Candela Announces New Technology and Indications at the 2017 American Academy of Dermatology (AAD) Annual Meeting	NASDAQ:ELOS	Syneron Medical Ltd. - Ordinary Shares
15/02/2017	06:00	PR Newswire (US)	Syneron Medical Reports Fourth Quarter 2016 Revenue of $82.9 Million and Full Year 2016 Revenue $298.1 Million	NASDAQ:ELOS	Syneron Medical Ltd. - Ordinary Shares
13/02/2017	08:00	PR Newswire (US)	Syneron Medical to Participate in Leerink Partners 6th Annual Global Healthcare Conference	NASDAQ:ELOS	Syneron Medical Ltd. - Ordinary Shares
07/02/2017	08:00	GlobeNewswire Inc.	Sientra Appoints Aesthetic Industry Leader Philippe A. Schaison to Board of Directors	NASDAQ:ELOS	Syneron Medical Ltd. - Ordinary Shares
31/01/2017	15:05	PR Newswire (US)	Syneron Medical Strengthens Senior Management Team with Appointment of Chief Human Resources Officer	NASDAQ:ELOS	Syneron Medical Ltd. - Ordinary Shares
30/01/2017	08:00	PR Newswire (US)	Syneron Medical to Report Fourth Quarter and Full Year 2016 Financial Results on February 15, 2017	NASDAQ:ELOS	Syneron Medical Ltd. - Ordinary Shares
11/11/2016	15:00	PR Newswire (US)	Syneron Medical to Participate in the Canaccord Genuity Medical Technologies and Diagnostics Forum	NASDAQ:ELOS	Syneron Medical Ltd. - Ordinary Shares
09/11/2016	06:00	PR Newswire (US)	Syneron Medical Reports Third Quarter 2016 Revenue of $71.5 Million	NASDAQ:ELOS	Syneron Medical Ltd. - Ordinary Shares
08/11/2016	08:00	PR Newswire (US)	Syneron Candela Announces FDA Clearance Of Profound™ SubQ To Improve The Appearance Of Cellulite, As Supported By Long Term...	NASDAQ:ELOS	Syneron Medical Ltd. - Ordinary Shares
17/10/2016	14:09	Edgar (US Regulatory)	Statement of Ownership (sc 13g)	NASDAQ:ELOS	Syneron Medical Ltd. - Ordinary Shares
17/10/2016	06:00	PR Newswire (US)	Syneron Medical Strengthens Senior Management and Announces Preliminary Third Quarter 2016 Revenue	NASDAQ:ELOS	Syneron Medical Ltd. - Ordinary Shares
08/09/2016	15:01	Edgar (US Regulatory)	Securities Registration: Employee Benefit Plan (s-8)	NASDAQ:ELOS	Syneron Medical Ltd. - Ordinary Shares
04/08/2016	06:00	PR Newswire (US)	Syneron Medical Reports Second Quarter 2016 Revenue of $75.0 Million and Non-GAAP EPS of $0.09	NASDAQ:ELOS	Syneron Medical Ltd. - Ordinary Shares
25/07/2016	08:00	PR Newswire (US)	Syneron Candela's PicoWay Picosecond Laser Receives U.S. FDA Clearance for Ultra-Short 785nm Wavelength	NASDAQ:ELOS	Syneron Medical Ltd. - Ordinary Shares
18/07/2016	08:00	PR Newswire (US)	Syneron Candela Announces FDA Clearance of High Energy UltraShape Power for Fat Destruction	NASDAQ:ELOS	Syneron Medical Ltd. - Ordinary Shares
18/07/2016	07:30	PR Newswire (US)	Syneron Medical to Report Second Quarter 2016 Financial Results on August 4, 2016	NASDAQ:ELOS	Syneron Medical Ltd. - Ordinary Shares
06/07/2016	15:09	Edgar (US Regulatory)	Initial Statement of Beneficial Ownership (3)	NASDAQ:ELOS	Syneron Medical Ltd. - Ordinary Shares
31/05/2016	05:06	Edgar (US Regulatory)	Specialized Disclosure Report (sd)	NASDAQ:ELOS	Syneron Medical Ltd. - Ordinary Shares
19/05/2016	06:00	PR Newswire (US)	Syneron Medical Reports First Quarter 2016 Revenue of $68.7 Million	NASDAQ:ELOS	Syneron Medical Ltd. - Ordinary Shares
27/04/2016	08:00	PR Newswire (US)	Syneron Medical to Report First Quarter 2016 Financial Results on May 19, 2016	NASDAQ:ELOS	Syneron Medical Ltd. - Ordinary Shares
31/03/2016	08:00	PR Newswire (US)	Syneron Candela Leads Energy Innovation Discussions at 36th Annual ASLMS Conference	NASDAQ:ELOS	Syneron Medical Ltd. - Ordinary Shares